Candel Therapeutics Inc (CADL) Financials

$11.21

$0.36 (3.32%)

As on 21-Sep-2026 16:00EDT

Market cap

$830 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	0.03	0.13	0.13
Cost of Revenue	0.51	0.85	0.99	23.98	0.99	0.23
Gross Profit	-0.51	-0.85	-0.99	-23.98	0.13	0.13
Operating Expenses	71.99	48.27	33.37	38.39	34.80	25.85
Operating Profit (EBIT)	-71.99	-48.27	-33.37	-38.39	-34.67	-25.73
Other Income	--	--	--	--	--	-10.40
Profit before Tax	-88.53	-38.18	-55.18	-37.94	-18.79	-36.12
Provision for Tax	--	--	--	--	-15.93	10.40
Profit after Tax (Net Income)	-88.53	-38.18	-55.18	-37.94	-18.79	-36.12
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-18.79	-36.12

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	126.13	51.92	66.33	12.75	47.71	64.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	69.33	64.28	3.01	14.27	25.19	19.71
Current Liabilities	12.69	9.00	37.53	14.18	5.62	5.36
Total Liabilities	220.83	125.20	106.87	41.20	78.52	89.21

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.99	5.46	3.06	4.40	6.57	4.26
Current Assets	204.16	119.73	103.80	36.80	71.95	84.95
Total Assets	220.83	125.20	106.87	41.20	78.52	89.21
Total Debt*	49.52	1.90	13.47	22.76	22.80	0.56
Net Current Assets	191.47	112.39	66.28	22.61	66.33	79.58

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-38.31	-27.02	-34.24	-31.42	-22.22
Cash Flow from Investing Activities	--	-0.56	-0.02	-0.28	-1.30	-1.84
Cash from Financing Activities	--	56.10	94.28	-0.12	19.97	71.80
Net Cash Inflow / Outflow	--	--	--	--	--	47.75

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.41	-0.70	-1.55	-1.31	-0.65	-1.04
Cash EPS ($)	--	-0.68	-1.52	-1.28	-0.62	-1.04
Adjusted Book Value ($)	--	0.95	1.86	0.44	1.65	1.85
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.70	-0.76	-1.18	-1.09	-0.64
Free Cash Flow per Share ($)	--	-0.71	-0.76	-1.20	-1.13	-0.69

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-57.15	-95.71	-71.57	-27.80	-171.69
ROE (%)	-99.44	-64.58	-139.56	-125.50	-33.61	-178.06
ROA (%)	-51.85	-32.91	-74.53	-63.38	-22.41	-56.67
EBIT Margin (%)	--	--	--	-114,012.90	-13,668.80	-28,856.80
Net Margin (%)	--	--	--	-122,383.87	-15,035.20	351.64
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	-0.75	--	--
EBIT Growth (%)	-304.57	32.07	-50.20	-106.86	52.63	-173.56
Net Profit Growth (%)	-299.94	30.80	-45.44	-101.87	47.97	-104.32
EPS Growth (%)	-139.53	0.55	-0.19	-1.01	0.38	0.31
Book Value Growth (%)	-2.89	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-8.12	-5.59	-1.12	-2.75	-7.50
Price / Book Value	6.88	5.97	4.65	3.34	1.08	4.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.01	-5.46	-4.21	-0.87	-0.27	-5.27
Close Price ($)	10.30	5.65	8.68	1.47	1.79	7.82
High Price ($)	11.36	13.68	14.60	3.06	8.10	14.78
Low Price ($)	4.35	4.25	1.16	0.66	1.40	5.51
Market Cap ($ Cr)	830.23	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.38	0.04	0.20	1.79	0.48	0.01
Short term debt to equity ratio	0.00	0.01	0.16	0.74	0.01	--
Current Ratio	16.09	13.31	2.77	2.59	12.81	15.84
Quick Ratio	16.09	--	--	--	--	--
Interest Coverage	-17.77	-17.02	-25.40	-13.62	-10.00	-680.58

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	0.00	0.00	0.00
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	295.23	121.57	6.11	364.51	1,976.60
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.